HSD17B13 anticorps (AA 81-110)

N° du produit ABIN7876884

L’anticorps anti-HSD17B13 Polyclonal Lapin est utilisé pour la détection de HSD17B13 dans des échantillons de Humain. Il a été validé pour WB et IHC (p).

Aperçu rapide pour HSD17B13 anticorps (AA 81-110) (ABIN7876884)

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HSD17B13 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-HSD17B13 anticorps

Épitope: AA 81-110

Fonction: HSD17B13 Antibody / DHB13 / 7-beta hydroxysteroid dehydrogenase 13

Purification: Antigen affinity

Immunogène: A portion of amino acids 81-110 from the human protein was used as the immunogen for this HSD17B13 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Titration of the HSD17B13 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the HSD17B13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur HSD17B13

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Autre désignation: HSD17B13

Sujet: HSD17B13 protein is an enzyme that plays a key role in the metabolism of steroids and lipids in the body. Specifically, it is involved in the conversion of various hormones and fatty acids, making it a critical player in maintaining metabolic homeostasis. Additionally, studies have shown that mutations or dysregulation of the HSD17B13 gene can lead to impaired lipid metabolism and contribute to the development of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. HSD17B13 protein is a potential therapeutic target for liver diseases.

UniProt: Q7Z5P4